Fluicell publishes 2022 Q4 Year-end report
Today, February 24 2023, Fluicell publishes the Q4 Year-end report for the period January to December, 2022. The…
Spheroid bioprinting for disease modeling
Spheroids are a powerful tool for in vitro tissue and disease modeling, with multiple applications across cancer and…
16
Feb
2023
Fluicell is growing
Do you want to be part of an innovative team pushing the boundaries in 3D bioprinting, engineered tissue-based…
30
Jan
2023
Fluicell CEO Newsletter 05, 2022
2022 has been a busy year for us at Fluicell. Not only have we this year released Biopixlar…
20
Dec
2022
Fluicell publishes report for the third quarter 2022
Today, November 30 2022, Fluicell publishes the interim report for the period July 1 to September 30, 2022….
30
Nov
2022
Biopixlar AER Innovation of the year nomination
Biopixlar AER is nominated as Innovation of the Year for the 2022 3D Printing Industry Awards! We at…
29
Nov
2022
Biopixlar biosafety cabinet installed
Erlab-Noroit has just completed a successful installation of a customized version of their H.Box Class II biosafety cabinet,…
22
Nov
2022
Fluicell at Australian bioprinting workshop
We are happy to announce that we are attending the 4th Australian Bioprinting Workshop, taking place at Univserity…
17
Nov
2022
Fluicell welcomes Sanna Sämfors
Fluicell welcomes Sanna Sämfors who joins Fluicell as Application Specialist. In her role, Sanna will be developing bioprinting…
24
Oct
2022